Skip to Content

317 M (Cimetidine 300 mg)

Pill imprint 317 M has been identified as Cimetidine 300 mg.

Cimetidine is used in the treatment of human papilloma virus; obesity; gerd; erosive esophagitis; duodenal ulcer (and more), and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Cimetidine 300 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cimetidine 300 mg 317 M
Cimetidine 300 mg 317 M Front
Cimetidine 300 mg 317 M Back
Cimetidine 300 mg 317 M
Cimetidine
Imprint:
317 M
Strength:
300 mg
Color:
Green
Size:
10.00 mm
Shape:
Five-sided
Availability:
Rx and/or OTC
Drug Class:
H2 antagonists
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-0317
Inactive Ingredients:
croscarmellose sodium
crospovidone
hypromelloses
soya lecithin
magnesium stearate
microcrystalline cellulose
polydextrose
polyethylene glycol
povidone
corn starch
sodium alginate
sodium lauryl sulfate
titanium dioxide
triacetin
vanillin
FD&C Blue No. 1
FD&C Yellow No. 6
D&C Yellow No. 10
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54569-3837 A-S Medication Solutions, LLC (repackager)
66267-0056 Nucare Pharmaceuticals Inc (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide